» Articles » PMID: 22518859

Detection of Methicillin-resistant Staphylococcus Aureus in Clinical Specimens from Cystic Fibrosis Patients by Use of Chromogenic Selective Agar

Overview
Specialty Microbiology
Date 2012 Apr 21
PMID 22518859
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the use of a chromogenic selective medium (MRSA ID) as a useful tool for the detection of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF) patient samples. Fifty-four MRSA isolates were detected by MRSA ID, while only 24/54 (44%) (odds ratio [OR], 2.79; 95% confidence interval [CI], 1.63 to 4.76) were detected by conventional methods. A chromogenic selective medium for MRSA detection may improve its surveillance in CF patients.

Citing Articles

Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.

Saiman L, Waters V, LiPuma J, Hoffman L, Alby K, Zhang S Clin Microbiol Rev. 2024; 37(3):e0021521.

PMID: 39158301 PMC: 11391703. DOI: 10.1128/cmr.00215-21.


The first report of Methicillin-resistant (MRSA) in cystic fibrosis (CF) patients in Saudi Arabia.

Banjar H, Al-Qahtani H, Yasin W, Al-Wgait W, Al-Amer H, Raja R Int J Pediatr Adolesc Med. 2020; 7(4):186-190.

PMID: 33319017 PMC: 7729253. DOI: 10.1016/j.ijpam.2019.10.005.


The History of Methicillin-Resistant in Brazil.

Andrade M, Luiz W, Souza R, Amorim J Can J Infect Dis Med Microbiol. 2020; 2020:1721936.

PMID: 33082892 PMC: 7563066. DOI: 10.1155/2020/1721936.

References
1.
Flayhart D, Hindler J, Bruckner D, Hall G, Shrestha R, Vogel S . Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol. 2005; 43(11):5536-40. PMC: 1287825. DOI: 10.1128/JCM.43.11.5536-5540.2005. View

2.
Sanders D, Bittner R, Rosenfeld M, Hoffman L, Redding G, Goss C . Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010; 182(5):627-32. PMC: 5450763. DOI: 10.1164/rccm.200909-1421OC. View

3.
Dasenbrook E, Checkley W, Merlo C, Konstan M, Lechtzin N, Boyle M . Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010; 303(23):2386-92. DOI: 10.1001/jama.2010.791. View

4.
Wellinghausen N, Kothe J . Evidence of coinfection with distinct strains of Burkholderia multivorans in a cystic fibrosis patient. Infection. 2006; 34(5):289-91. DOI: 10.1007/s15010-006-5608-4. View

5.
Leahy T, Yau Y, Atenafu E, Corey M, Ratjen F, Waters V . Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatr Pulmonol. 2011; 46(5):489-96. DOI: 10.1002/ppul.21383. View